Last reviewed · How we verify
Unresectable, advanced or recurrent gastric cancer
Approved treatments
- Opdivo · Bristol-Myers Squibb
Opdivo works by blocking the PD-1 receptor on immune cells, allowing them to attack cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Unresectable, advanced or recurrent gastric cancer patent landscape — cliff calendar, originator estates, attackable patents
- Unresectable, advanced or recurrent gastric cancer treatment landscape brief
- Unresectable, advanced or recurrent gastric cancer treatment updates RSS
Frequently asked questions about Unresectable, advanced or recurrent gastric cancer
What drugs treat Unresectable, advanced or recurrent gastric cancer?
Tracked treatments include Opdivo.
What is the treatment for Unresectable, advanced or recurrent gastric cancer?
Standard treatment for Unresectable, advanced or recurrent gastric cancer includes Opdivo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Unresectable, advanced or recurrent gastric cancer patent cliff · Unresectable, advanced or recurrent gastric cancer CI report
- Treatment: Opdivo · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing